Anuraag Vazirani

21 November 2024

World experts reflecting on the future of pancreatic cancer treatment

“Surgery can cure”, said Markus Büchler, director of the newly opened Botton-Champalimaud Pancreatic Cancer Centre, in Lisbon, during his talk. Büchler was referring to a form of pancreatic cancer surgery called the “triangle operation”, in which he has done pioneering work.

Why We Get Sick: Immune-mediated Modulation of Systemic Metabolism in Context of Disease

Host

Klaas van Gisbergen, PhD, Tissue Immunity Lab


Venue

Seminar room

18 November 2024

How Tiny Fish Reveal Big Insights into Behaviour

The reasons why one animal chooses one path over another, or behaves differently from others, can often seem enigmatic. But a team led by Claire Wyart’s group at the Paris Brain Institute (ICM), in collaboration with Michael Orger’s lab at the Champalimaud Foundation (CF), has shed light on these differences, revealing the dynamic relationship between an animal’s internal states and its surroundings.

18 November 2024

Parkinson’s paradox: when more dopamine means more tremor

Parkinson's disease (PD) is a progressive neurological disorder known for its characteristic motor symptoms: tremor, rigidity, and slowness of movement. Among these, rest tremor—a shaking that occurs when muscles are relaxed—is one of the most recognisable yet least understood.

ICDP STUDENTS 2024

ICDP 2024

ICDP 2024

 

INDP STUDENTS 2024

INDP 2024

Anna Beltramini
Athira Dilip
Diana Bernardo
Francesco Costantino Costabile
Hannah Vormann
Joseph Tutt
Madhuri Srinivasan
Pedro Dias
Shahar Haim
Shrivas Chaterji
Simon Zamora

 

INDP 2024

 

13 November 2024

CaixaResearch Health Research Contest Awards Researchers at CF, GIMM & i3S

For this edition of the contest, a total of nine groundbreaking biomedical and health projects spearheaded by research institutions in Portugal were selected. Alongside CF, GIMM, and i3S, awards were also granted to projects from the Instituto de Tecnologia Química e Biológica António Xavier da Universidade Nova de Lisboa (ITQB NOVA), Instituto de Investigação em Ciências da Vida e da Saúde (ICVS) and Instituto de Biomedicina (iBiMED). These nine selected projects will receive more than €7.6 million in support.

Subscribe to Champalimaud Research
Loading
Please wait...